Optimally Aligned Nerve Scaffolds with Sustained Astaxanthin Release Improve the Inflammatory Microenvironment through Mitophagy Activation
Source abstract
Abstract
Abstract Effective repair of peripheral nerve injury (PNI) depends on the scaffold orientation and immunomodulatory capabilities of functionalized scaffolds, both of which substantially influence nerve regeneration. In this study, composite nerve scaffolds incorporating astaxanthin (AXT) and polycaprolactone (PCL) are developed to investigate the influence of scaffold orientation and blend concentration on cellular behavior, including adhesion, migration, and proliferation. In vitro analysis identifies 0.2% AXT/PCL fabricated at a rotational speed of 400 rpm as the optimal configuration for facilitating directed cell growth and guiding nerve repair. Moreover, the controlled release of AXT improves the microenvironment by preserving mitochondrial homeostasis, promoting mitophagy, and reducing oxidative stress and inflammation. In vivo assessments reveal that the AXT/PCL group (0.2% AXT/PCL‐400) achieves better morphological, histological, electrophysiological, and functional recovery than the PCL, AXT/PCL+M0, and AXT/PCL+M4 groups, approaching the outcomes observed in the autograft (Auto) group. Moreover, the AXT/PCL+M4 group demonstrates better regenerative outcomes than the PCL and AXT/PCL+M0 groups, underscoring the critical role of mitophagy in regulating the regenerative microenvironment.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Nerve injury and regeneration · Anesthesia and Neurotoxicity Research · Graphene and Nanomaterials Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Orthopedics Shanghai Tenth People's Hospital School of Medicine Tongji University 301 Yanchang Road Shanghai 200072 P. R. China
Fudan University Affliated Stomatological Hospital Shanghai 200040 P. R. China
Department of Orthopedics the First Affiliated Hospital of Bengbu Medical University No. 287 Changhuai Road Bengbu Anhui 233004 P. R. China
The Affiliated Hospital of Southwest Medical University Luzhou Sichuan 646600 P. R. China
Funding
Science and Technology Commission of Shanghai Municipality
References (53)
Show source-provided references
1. Wang P. · Adv. Healthcare Mater. · 2024
2. 10.1021/acsami.6b0355510.1021/acsami.6b03555 ↗
3. 10.1016/j.mattod.2021.09.01410.1016/j.mattod.2021.09.014 ↗
4. 10.1002/adhm.20200060410.1002/adhm.202000604 ↗
5. 10.1016/j.xcrm.2024.10179110.1016/j.xcrm.2024.101791 ↗
6. 10.1002/advs.20220574410.1002/advs.202205744 ↗
7. 10.1002/adhm.20240116010.1002/adhm.202401160 ↗
8. 10.1021/acsnano.3c0178910.1021/acsnano.3c01789 ↗
9. 10.1002/adma.20240825510.1002/adma.202408255 ↗
10. 10.1016/j.bioactmat.2023.08.00810.1016/j.bioactmat.2023.08.008 ↗
11. Zhang F. · J. Mater. Chem. B · 2024
12. 10.1039/D2TB01624A10.1039/D2TB01624A ↗
13. Zhao J. · Adv. Sci. · 2024
14. 10.1021/acsnano.9b0759810.1021/acsnano.9b07598 ↗
15. 10.1016/j.bioactmat.2024.12.00910.1016/j.bioactmat.2024.12.009 ↗
16. 10.1186/s12951-024-03018-x10.1186/s12951-024-03018-x ↗
17. 10.1021/acsnano.3c1310210.1021/acsnano.3c13102 ↗
18. 10.1002/advs.20230251910.1002/advs.202302519 ↗
19. 10.1002/advs.20220210210.1002/advs.202202102 ↗
20. 10.1002/adhm.20230115110.1002/adhm.202301151 ↗
21. 10.1021/acsmaterialslett.2c0068410.1021/acsmaterialslett.2c00684 ↗
22. 10.1016/j.jconrel.2024.01.04310.1016/j.jconrel.2024.01.043 ↗
23. Fang J. · Advanced Technol. in Neuroscience · 2024 · 1
24. Ge G. · Adv. Funct. Mater. · 2023 · 33
25. 10.1002/jobm.20210039110.1002/jobm.202100391 ↗
26. Davinelli S. · Astaxanthin in Skin Health, Repair, and Disease: A Comprehensive Review. Nutrients · 2018 · 10
27. 10.3390/md1812064210.3390/md18120642 ↗
28. 10.1080/13510002.2024.242227110.1080/13510002.2024.2422271 ↗
29. 10.1016/j.jnutbio.2009.01.01110.1016/j.jnutbio.2009.01.011 ↗
30. Kidd P. · Altern. Med. Rev. · 2011 · 16 · 355
31. Zhang H. · Mar Drugs · 2024 · 22
32. 10.1080/1040869059095718810.1080/10408690590957188 ↗
33. 10.3389/fbioe.2022.85065010.3389/fbioe.2022.850650 ↗
34. 10.1016/j.bioactmat.2023.11.01610.1016/j.bioactmat.2023.11.016 ↗
35. 10.1155/2016/690432710.1155/2016/6904327 ↗
36. 10.3233/CH-15201910.3233/CH-152019 ↗
37. 10.1007/s10456-013-9376-310.1007/s10456-013-9376-3 ↗
38. 10.1039/C6NR05075A10.1039/C6NR05075A ↗
39. 10.1039/D3BM00920C10.1039/D3BM00920C ↗
40. 10.1002/mabi.20230047610.1002/mabi.202300476 ↗
41. Yao Z. · Adv. Fiber Mater. · 2024
42. 10.1016/j.bioactmat.2024.07.01810.1016/j.bioactmat.2024.07.018 ↗
43. 10.1021/acsami.6b0519910.1021/acsami.6b05199 ↗
44. 10.1016/j.biomaterials.2013.09.07710.1016/j.biomaterials.2013.09.077 ↗
45. Li M. · Advanced Technol. in Neuroscience · 2024 · 110.4028/b-khe5ND ↗
46. Liu N. · Advanced Technol. in Neuroscience · 2024 · 1
47. Sztretye M. · Oxid Med Cell Longev. · 2019
48. Ding F. · Antioxidants · 2022 · 11
49. 10.1016/j.biopha.2023.11423010.1016/j.biopha.2023.114230 ↗
50. 10.1016/j.algal.2023.10310710.1016/j.algal.2023.103107 ↗
51. 10.1016/j.foodchem.2022.13503610.1016/j.foodchem.2022.135036 ↗
52. 10.1039/D2FO01673G10.1039/D2FO01673G ↗
53. 10.1002/advs.20230536310.1002/advs.202305363 ↗